Volver al ranking

Thumbnails similares a How Does the FDA Approval of Risankizumab Impact Pediatric Psoriasis and PsA? With Amy Paller, MD

20 vecinos (thumb_512) · 109 views · HCPLive · Estados Unidos

How Does the FDA Approval of Risankizumab Impact Pediatric Psoriasis and PsA? With Amy Paller, MD

HCPLive

@hcplivenews

109Estados Unidos
3Enlicitide Receives FDA Approval for Hypercholesterolemia Following CORALreef Trials

HCPLive

@hcplivenews

681Estados Unidos76
17Furoscix ReadyFlow (Furosemide) and its Impact on HF, CKD Edema Treatment

HCPLive

@hcplivenews

374Estados Unidos69
5Afrezza’s Pediatric Approval and Improving Adolescent Diabetes Care

HCPLive

@hcplivenews

160Estados Unidos72
1Highlighting FDA-Approved Therapies in Atopic Dermatitis, With Chris Bunick, MD, PhD

HCPLive

@hcplivenews

152Estados Unidos77
12FIND-CKD Expands Finerenone Evidence Beyond Diabetic CKD, With Rajiv Agarwal, MD

HCPLive

@hcplivenews

131Estados Unidos70
7Total Plaque Volume Indicates Patients With 0 CAC May Still be at Risk

HCPLive

@hcplivenews

120Estados Unidos71
2Ruxolitinib, Tapinarof, Roflumilast: What's New for Pediatric AD

HCPLive

@hcplivenews

102Estados Unidos76
16VESALIUS-CV: Evolocumab Prevents Cardiovascular Disease in High-Risk Diabetes

HCPLive

@hcplivenews

96Estados Unidos70
11MAESTRO-NASH: Resmetirom May Reduce Cardiovascular Risk in MASH, With or Without Statins

HCPLive

@hcplivenews

86Estados Unidos70
19Juana Hutchinson-Colas, MD, OB/GYN

RWJBarnabas Health

@rwjbarnabashealth

86Estados Unidos69
6Tezepelumab Cuts Severe Asthma Exacerbations 70% in Real-World Patients | ATS 2026

HCPLive

@hcplivenews

68Estados Unidos71
10Omalizumab vs Oral Immunotherapy for Multifood Allergy

HCPLive

@hcplivenews

65Estados Unidos70
8Closing Gaps in IgA Nephropathy Diagnosis and Treatment, With Brad Rovin, MD

HCPLive

@hcplivenews

60Estados Unidos71
4Implications of the Phase 4 Trial of Metreleptin in Patients With General Lipodystrophy

HCPLive

@hcplivenews

55Estados Unidos72
20Metreleptin-Neutralizing Antibodies Do Not Impact Treatment Outcomes in Generalized Lipodystrophy

HCPLive

@hcplivenews

40Estados Unidos69
15FMD Peak Systolic Velocity May Lead to Comprehensive Clinical Guidelines

HCPLive

@hcplivenews

33Estados Unidos70
9HPA-Axis Assessment Allows for Improved Corticosteroid Response Analysis

HCPLive

@hcplivenews

32Estados Unidos71
13Diagnosing Non-IgE Food Hypersensitivity | Brian Lacy, MD, PhD | EAC 2026

HCPLive

@hcplivenews

31Estados Unidos70
14Key Non-Medication Clinical Pearls for Dermatologists, With Matthew Zirwas, MD

HCPLive

@hcplivenews

21Estados Unidos70
18How Should Clinicians Address the Link Between Atopic Dermatitis and Allergy? With Jay Lieberman, MD

HCPLive

@hcplivenews

13Estados Unidos69